Evidence map›Paper›PMID 41859571›Full record

ArticleCureus2026

Natural Polyphenols Versus Standard Therapy: Effects on Neuroinflammation and Alpha-Synuclein Expression in a 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Induced Mouse Model of Parkinson's Disease.

Shalini Singh, Karan Suneja, Ipshita Jain, Suyog Sindhu, Satyendra Singh, Rishi Pal, Rakesh Dixit, Rajendra Nath

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shalini SinghPharmacology and Therapeutics, King George's Medical University, Lucknow, IND.
Karan SunejaPharmacology and Therapeutics, King George's Medical University, Lucknow, IND.
Ipshita JainPharmacology and Therapeutics, King George's Medical University, Lucknow, IND.
Suyog SindhuPharmacology and Therapeutics, King George's Medical University, Lucknow, IND.
Satyendra SinghCenter for Advanced Research, King George's Medical University, Lucknow, IND.
Rishi PalPharmacology and Therapeutics, King George's Medical University, Lucknow, IND.
Rakesh DixitPharmacology and Therapeutics, King George's Medical University, Lucknow, IND.
Rajendra NathPharmacology and Therapeutics, King George's Medical University, Lucknow, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuronal loss, α-synuclein aggregation, and chronic neuroinflammation. While levodopa (L-DOPA) + carbidopa remains the cornerstone of symptomatic management, long-term use is associated with motor complications, prompting interest in adjunctive therapies targeting non-dopaminergic mechanisms. Polyphenolic compounds such as resveratrol and curcumin have demonstrated neuroprotective potential through antioxidant and anti-inflammatory actions. This study aimed to comparatively evaluate the effects of L-DOPA + carbidopa, resveratrol, curcumin, and their combination, resveratrol + curcumin, on motor function and biochemical markers in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of PD. Methodology An experimental study was conducted using 36 adult female C57BL/6 mice randomly allocated into six groups (

Indexed as

neuroprotectionparkinson diseasepolyphenolstumor necrosis factor-alphaα-synuclein

Identifiers

PMID41859571
PMCPMC12996378

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.